// App-Quantinova.ai

P528 : Complications of IBD in the anti-TNF era: reason for optimism?

Researchers

Presenter

  • G. Fuhler

Principal Investigators

  • A. Edel

  • F. Lindenburg

  • L. Peyrin-Biroulet

  • C.J. van der Woude

  • R. Ouwendijk

  • M. Rijk

  • R. Beukers

  • R. Quispel

  • A. van Tilburg

  • T. Tang

  • H. Smalbraak

  • K. Bruin

Medical Centers

  • Nancy University Hospital, Universite de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France

  • Albert Schweitzer Hospital, Gastroenterology and Hepatology, Rotterdam, Netherlands

  • Lievensberg Hospital, Internal Medicine, Bergen op Zoom, Netherlands,

  • Sint Franciscus Gasthuis, Gastroenterology & Hepatology, Rotterdam, Netherlands

  • IJsselland Hospital, Gastroenterology & Hepatology, Capelle aan den IJssel, Netherlands

  • Leiden University Medical Centre, Gastroenterology and Hepatology, Leiden, Netherlands

  • Ikazia Hospital, Gastroenterology and Hepatology, Rotterdam, Netherlands

  • Reinier de Graaf Gasthuis, Gastroenterology and Hepatology, Rotterdam, Netherlands

  • Ikazia Hospital, Gastroenterology and Hepatology, Rotterdam, Netherlands

  • Tweesteden Hospital, Gastroenterology & Hepatology, Tilburg, Netherlands

  • Franciscus Hospital, Gastroenterology and Hepatology, Roosendaal, Netherlands

Locations

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Osteoporosis

  • Venous thrombosis

  • Osteopenia

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • Ubiquitin A-52 Residue Ribosomal Protein Fusion Product 1

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved